Products
Browse drug products linked to peptide identities and clinical context.
- On page
- 20
- API
- live
Total
110
Stack
Browse drug products linked to peptide identities and clinical context.
Measured material: whole product
parenteral_other · Hypoglycemic Agents
Subcutaneous
—
Subcutaneous · Bone Density Conservation Agents
MOUNJARO (tirzepatide) injection, for subcutaneous use, contains tirzepatide, a once weekly GIP receptor and GLP-1 receptor agonist. It is a 39-amino-acid modified peptide based on the GIP sequence. Tirzepatide contains 2 non-coded amino acids (aminoisobutyric acid, Aib) in positions 2 and 13, a C-terminal amide, and Lys residue at position 20 that is attached to 1,20-eicosanedioic acid via a linker.
Tymlos is a man-made form of parathyroid hormone that exists naturally in the body. Abaloparatide increases bone mineral density and bone strength, which may prevent fractures. Tymlos is a prescription medicine used to treat osteoporosis in postmenopausal women who have a high risk of bone fracture.... · Injection, solution
Subcutaneous, intramuscular, or Intravenous infusion · Subcutaneous, intramuscular, or Intraven · Subcutaneously or intramuscularly Inject · intranasal administration in an intranasal device · subcutaneous injection · Hypoglycemic Agents
parenteral_other · Injection
oral · Capsule
—
—
oral · Tablet
Subcutaneous · Injection, powder, lyophilized, for solution
intramuscular or Subcutaneous use · Antidiuretic Agents
Intramuscular Injection · Anti-Testosterone Agents
—
—
subcutaneous · Implant
intravenous · Injection, solution
3D
3D
3D
3D
2D
2D
2D
2D
3D
3D